Titouan Launay

ORCID: 0000-0001-8736-6678
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • COVID-19 Clinical Research Studies
  • COVID-19 epidemiological studies
  • Influenza Virus Research Studies
  • Bacterial Infections and Vaccines
  • Dermatological diseases and infestations
  • Atrial Fibrillation Management and Outcomes
  • Suicide and Self-Harm Studies
  • COVID-19 and Mental Health
  • Pneumonia and Respiratory Infections
  • Vaccine Coverage and Hesitancy
  • Allergic Rhinitis and Sensitization
  • Vector-borne infectious diseases
  • SARS-CoV-2 and COVID-19 Research
  • Cardiac electrophysiology and arrhythmias
  • Healthcare professionals’ stress and burnout
  • Myasthenia Gravis and Thymoma
  • Tuberculosis Research and Epidemiology
  • Respiratory viral infections research
  • Infection Control and Ventilation
  • Peripheral Nerve Disorders
  • Health, Medicine and Society
  • Zoonotic diseases and public health
  • Inflammatory mediators and NSAID effects
  • COVID-19 and healthcare impacts
  • Musculoskeletal pain and rehabilitation

Institut Pierre Louis d‘Épidémiologie et de Santé Publique
2019-2025

Inserm
2019-2025

Sorbonne Université
2019-2025

Sorbonne Paris Cité
2024

Centre Hospitalier Régional Universitaire de Brest
2020

Hôpital Saint-Antoine
2019

Assistance Publique – Hôpitaux de Paris
2019

Several French regions where coronavirus disease (COVID-19) has been reported currently show a renewed increase in ILI cases the general practice-based Sentinelles network. We computed number of excess by region from 24 February to 8 March 2020 and found correlation with COVID-19 so far. The data suggest larger circulation severe acute respiratory syndrome 2 (SARS-CoV-2) population than apparent confirmed cases.

10.2807/1560-7917.es.2020.25.14.2000326 article EN cc-by Eurosurveillance 2020-04-09

Lyme borreliosis (LB) is the most frequent vector-borne disease in France. Since 2009, surveillance of LB conducted by a sentinel network general practitioners (GPs). This system, conjunction with national hospitalisation database was used to estimate incidence and describe characteristics France.To estimated trends GP consultations hospital admissions for France identify risk groups high-incidence regions.From 2011 2016, mean yearly rate cases 53 per 100,000 inhabitants (95% CI: 41-65)...

10.2807/1560-7917.es.2019.24.11.1800134 article EN cc-by Eurosurveillance 2019-03-14

The French national surveillance of pertussis consists several units, including general practitioners (GPs). Here, we report on the clinical characteristics cases from January to December 2024 primary care in France. During this period, a total 689 were reported by GPs participating surveillance. incidence rate practice was estimated be 244 per 100,000 inhabitants (95 % CI: 224-264). Sixty-one cent female and 86 had received at least one dose vaccine. Among vaccinated with three doses, 77...

10.1016/j.vaccine.2025.126862 article EN cc-by Vaccine 2025-02-13

Epidemic forecasting and policy evaluation rely on mathematical models to predict infectious disease trends assess the impact of public health policies. Traditional typically require extensive epidemiological data may struggle in data-limited settings. Transformer-based, foundation AI have demonstrated strong predictive capabilities various time series applications. We investigated whether they can be basis a new epidemic modeling framework. evaluated five - TabPFN-TS, TimeGPT, TimesFM,...

10.1101/2025.02.24.25322795 preprint EN cc-by-nc medRxiv (Cold Spring Harbor Laboratory) 2025-02-25

An increase in hospitalizations for respiratory illnesses due to Mycoplasma pneumoniae was reported France late October 2023. Data primary care are scarce and microbiological or radiological investigations not routinely recommended community-acquired pneumonia. We computed weekly incidence rates of pneumonia bronchiolitis cases from the electronic records French general practitioners January 2016 August 2024. These incidences were described light Covid-19 pandemic, overall by age group. For...

10.1186/s41479-025-00159-x article EN cc-by-nc-nd Pneumonia 2025-03-25

In France, social distancing measures have been adopted to contain the spread of COVID-19, culminating in national Lockdowns. The use hand washing, hydro-alcoholic rubs and mask-wearing also increased over time. As these are likely impact transmission many communicable diseases, we studied changes common infectious diseases incidence France during first year COVID-19 circulation. We examined weekly acute gastroenteritis, chickenpox, respiratory infections bronchiolitis reported general...

10.1371/journal.pone.0258391 article EN cc-by PLoS ONE 2021-10-11

BackgroundVaccination policy in France was previously characterised by the coexistence of eight recommended and three mandatory vaccinations for children younger than 2 years old. These 11 vaccines are now all born after 1 January 2018.AimTo study French population's opinion about this new to assess factors associated with a positive during changing phase.MethodsA cross-sectional survey vaccination conducted from 16 November-19 December 2017 among GrippeNet.fr cohort. Data were weighted age,...

10.2807/1560-7917.es.2019.24.25.1900053 article EN cc-by Eurosurveillance 2019-06-20

Lockdowns and physical distancing have dramatically limited the circulation of SARS-CoV-2 other common communicable infections. However, little is known about their impact on head lice scabies.To assess 2020 French National lockdowns (17 March-11 May 2020, 30 October-15 December 2020) recommendations (from February dynamics scabies infestations.The weekly sales topical treatments, treatments oral ivermectin were extracted from database healthcare science company IQVIA (60% all retail...

10.1111/ced.15054 article EN Clinical and Experimental Dermatology 2021-12-10

Introduction In France, three complementary surveillance networks involving hospitals and paediatrician practices currently allow pertussis among infants (<1 year old) children (1–12 years old). Data on incidences adolescents (13–17 adults (≥ 18 years) are scarce. 2017, a sentinel system called Sentinelles network, was implemented general practitioners (GPs). Aim The purpose of network is to assess incidence, monitor the cases’ age distribution evaluate impact country’s vaccination...

10.2807/1560-7917.es.2022.27.17.2100515 article EN cc-by Eurosurveillance 2022-04-28

Bed bug infestations have been increasing worldwide since the 2000s. Their consequences for health range from skin reactions to major psychological distress. However, epidemiological data is still lacking. This study estimated incidence of general practice consultations related bed bugs in France and evaluated factors associated with repercussions on everyday life. We conducted a prospective observational March 2019 April 2020 among 217 GPs France. Annual monthly GP were reported cases....

10.1371/journal.pone.0308990 article EN cc-by PLoS ONE 2024-08-27

Concomitant nonsteroidal anti-inflammatory drug (NSAIDs) and antithrombotic use is associated with an increased risk of bleeding, mainly gastrointestinal. The goal this study was to quantify the transient increase in hospitalization for bleeding NSAID patients treated antiplatelet agents or anticoagulants. We performed a unidirectional case-crossover using EGB (Échantillon généraliste de bénéficiaires), permanent random sample French nationwide health database. Patients receiving therapy...

10.1002/jcph.2003 article EN The Journal of Clinical Pharmacology 2021-11-17

Background Most studies published to date have investigated the impact of COVID-19 pandemic on suicidal acts using hospital data. Trends from primary care in a country such as France are crucial, individuals may not consult services after suicide attempts (SAs) but rather see their general practitioner (GP). Objectives We aimed evaluate whether incidence and characteristics SAs completed suicides (CSs) reported French GPs were different during than those before. Methods findings conducted...

10.1371/journal.pone.0278266 article EN cc-by PLoS ONE 2022-12-15

10.1016/j.admp.2020.03.112 article FR Archives des maladies professionnelles et de médecine du travail/Archives des maladies professionnelles et de l'environnement 2020-09-28
Coming Soon ...